SUMMARY -It has recently been demonstrated that vessel dilation induced by several physiological agents is dependent on an intact vascular endothelium. In order to explain this endothelium dependence, it has been hypothesized that a still unknown chemical substance, generically named Endothelium Dependent Relaxing Factor (EDRF) is necessary for physiological vasodilation. The role of this EDRF in the cerebrovascular physiology is not yet well understood. In this article the cerebrovascular physiological control is reviewed in relationship with possible EDRF actions. The importance of endothelial lesions in the cerebrovascular responses is discussed.
and of lipoxygenase, but not of cyclooxygenase, it has been proposed that EDRF might be an unstable oxidation product of the arachidonic acid formed via the lipoxygenase pathway 3,16. However, in a recent study using aortic preparation from rabbit, alone and in cascade experiments with isolated perfused coronary preparations, Griffith et al. 22 demonstrated that EDRF is not a lipoxygenase derivative or a free radical. They suggested that EDRF is an unstable compound with a carbonyl group at or near its active site. Moreover, by changing the length of the intervening tubing between aortic and coronary preparations, they were able to calculate the half-life of EDRF as 6.3 ± 0.6 sec.
These authors concluded that EDRF is probably an aldehyde, ketone or lactone.
The regulation of cerebrovascular tonus is closely related to the brain tissue metabolic demands 34.
The adequacy of cerebral blood flow (CBF) is maintained despite large variations in systemic parameters such as arterial blood pressure, blood viscosity, and cardiac output 5,27,34,42.
The mechanism of this strict control is still poorly understood 5,28.
in pathological situations where cerebrovascular endothelium is affected (e.g., arterial hypertension, head injury), the coupling of CBF to brain metabolism is disturbed 21,30,31,49,50,60.
Thus, it seems likely that, in addition to its barrier role, the endothelial layer may play an active role in modulating cerebrovascular reactivity in normal and abnormal circumstances 54. The following sections will discuss the neurogenic, chemical and metabolic regulation of CBF and their possible relationship to the endothelium dependent relaxing factor.
EDRF AND THE CEREBROVASCULAR NEUROGENIC CONTROL.
Two distinct types of nerve ending can be distinguished in the walls of pial vessels by the use of ultrastructural techniques.
One type is derived from fibers that originate in the superior cervical ganglion.
It contains dense granular vesicles and is assumed to be adrenergic.
The other, observed even in animals pretreated with 6-hydroxydopamine or 5-hydroxydopamine, contains agranular vesicles and is generally assumed to be cholinergic 36.
Corresponding with this ultrastructural evidence, functional studies of cerebral vessels in vitro have distinguished two types of response to transmural nerve stimulation (TNS).
Stimulation of sympathetic nerves produces a contractile response in the pial vessels of rabbit, dog, sheep and monkeyAfter sympathetic denervation or treatment with guanethidine, nerve stimulation produces dilator response in pial vessels of several species.
This dilator response is presumably cholinergically mediated 7. In addition to the sympathetic and parasympathetic innervation, other systems can be visualized by immunohistochemical techniques.
These fibers contain peptides such as vasoactive intestinal polypeptide (VIP)33 and substance P10, or monoamines such as serotonin 6 2 .
Adrenergic
innervation -Adrenergic fibers originating in the ipsilateral superior cervical ganglion innervate both pial and intracerebral vessels 14,28.
in support of this is the fact that all adrenergic fibers disappear after superior cervical ganglionectomy 9.36.
Also, it has been shown that adrenergic fibers originating in the locus coeruleus may innervate capillaries 2 4.
However, it is questionable that adrenergic fibers originating in the brain stem truly innervate cerebral vessels, since in many cases the nerve fibers are separated from vessels by a thick basement membrane 28 .
With catecholamine fluorescence techniques the density and distribution of adrenergic fibers have been shown to be very similar in pial arteries of several animals and of humans H /?-, a x -and a 2 -adrenergic receptors have been identified and characterized in experiments using pharmacological models 9,14.55. in the peripheral vessels generally a receptors mediante vasoconstriction while ¡3 receptors mediate vasodilation.
This appears to be also true in the brain vasculature 5,54,55. In the cat, stimulation of the cervical sympathetic nerves produces pial arteriolar vasoconstriction, as well as a mild decrease in CBF 2 8.
The magnitude of CBF decrease caused by sympathetic stimulation depends on the species studied 7 .
Also, no significant constrictor response was detectable in smaller arterioles (<100um)6i. The physiological significance of the pial arteries' constriction by sympathetic nerve stimulation is not clear 7 On the other hand, studies of blood flow suggested that intraparenchymal vessels are generally quite responsive to catecholamine, and that adrenoceptors in capillaries may modify water permeability as well as blood flow 5.
What is difficult to assess by this approach is the contribution of metabolic changes to vascular changes 14.
Additional problems include wide variability in the responsiveness of different vessels in one species and in vessels from other species 14.17. For example, norepinephrine-induced contraction of human and monkey cerebral arteries are mediated by a x adrenoreceptors, while in dogs this effect appears to be mediated by <* 2 adrenoreceptors 55. Cerebral blood vessels responses to sympathetic nerve stimulation are relatively weak, clearly attributable to the very low responsi veness of their a-adrenergic receptors to norepinephrine 28-55.
This has led some investigators to suggest that cerebrovascular a-adrenoreceptors are different from those found in peripheral arteries 8.14.
Stimulation of /?-adrenergic receptors causes cerebrovascular dilation. Evidence derived from a large variety of vascular preparations seems to exclude any dependence of this ^-adrenergic dilation on the endothelium 54,55. Of interest, however, is the fact that lack of endothelial cells potentiates the vaso constriction effect of adrenergic agents.
It is possible that viable endothelial cells could constantly release a specific factor acting on the adrenergic receptor-mediated mechanism of constriction 54.
This finding may be of considerable importance in understanding pathophysiological phenomena involving alterations of endothelial func tion, whether by mechanical lesion 28 or chemical lesion 50.
This endothelial role in the modulation of adrenergic cerebral vasoconstriction is likely to be related to development of cerebral vasospasm following traumatic brain injury or subarachnoid hemorrhage 26,47. Also, it appears to be related to the vasoparalysis that follows such pathological states 31,50.
Although the lack of EDRF may not be the only cause of the abnormal vascular behavior in these pathological states, it seems likely that the endothelial cells may play an active role in modulating cerebrovascular responses to adrenergic stimuli 54.
Cholinergic innervation -Pial arteries are supplied with a well developed plexus of nonsympathetic cholinergic nerves.
The close association of their endings with the smooth muscle cells at the surface of the media layer fulfills accepted ultrastructural criteria for a functioning neurovascular relationship 9,28.
The presence of muscarine receptors in intracerebral microvessels has been more controversial. It is believed that the cholinergic innervation of the intracerebral vessels, in the case of small arterioles and capillaries, is of intracerebral origin since there is no peri vascular space at this vascular level.
This system would parallel the adrenergic system arising from the locus coeruleusis.
Although there is no direct evidence that such a system exists 14,28 ) indirect evidence supports the presence of a cholinergic control of the cerebral vasculature.
For example, administration of acetylcholine intravascularly dilates pial arterioles and increases cerebral blood flow. Carbachol applied locally dilates pial arteries 50.
The autoregulatory cerebral vasodilation following a decrease in systemic arterial blood pressure is blocked by atropine 36. The currently observed presence of muscarinic binding sites and choline acetyltransferase (ChAT) activity in brain capillary fractions also suggests that there may be a cholinergic innervation of brain capillaries 13,15,51. However, this ChAT activity could be due to contamination by brain tissue instead of ChAT activity in the actual vessels' wall.
Thus, the ChAT data alone is not sufficient to support the idea of cholinergic control of intracerebral arterioles and capillaries 14 . Parasympatho mimetic compounds produce either a relaxation or a contraction of the cerebral vasculature. The relaxation occurs at low doses, and the response is inhibited in a competitive manner by atropine-The contraction occurs with high doses and appears to be mediated by muscarinic receptors 9. When cholinergic fibers are activated by transmural electrical stimulation of cerebral arteries from cats, they induce significant vasodilation 7,28.
This vasodilation is not blocked by atropine 36. Thus, besides its direct postjunctional vasodilatory action on muscarinic receptors in the vascular smooth muscle, cholinergic innervation can also promote pial vasodilation indirectly, through an inhibition of the norepinephrine release via the nicotinic receptors present on the perivascular sympathetic fibers 9 .
Recently, in vitro studies have shown that Ach-induced relaxation of large cerebral arteries of cats and rabbits is dependent upon intact endothelium 35,54 } suggesting that EDRF may play a role on the choli nergic control of cerebral circulation. The in vitro findings may not reflect the true mechanism of cholinergic control of cerebral circulation.
As the nerve terminals lie at the arteries' adventitial-medial junction, it would be virtually impossible for neuronally released Ach to traverse the medial mass and reach the endothelium, except perhaps in third and fourth order arterioles where the medial layer is only the width of one or two muscle cells.
However, the density of cholinergic innervation is extremely sparse in small arteries and great in larger muscular arteries 43.44. Demons tration of L//]-quinuclidinylbenzilate (QNB) binding sites in the particulate fraction of collagenase-treated cerebral vessel preparation strongly suggests that muscarinic receptors are located in the membrane of capillary endothelial cells. More muscarinic binding sites were found in microvessel fractions than in capillaries, suggesting that in the former preparation, [ 3 //]QNB probably binds to smooth muscle cells as well as to the endothelium13. Tnus, Ach-induced relaxation of large cerebral vessels may be not dependent only upon EDRF. The presence of Ach receptors in the endothelial cells membrane suggests that EDRF play a role in the intracerebral vessel tonus control and may participate in the capillary blood flow regulation.
Lesion of the endothelium of pial microvessels in vivo48 by exposure of the vessels to filtered light from a mercury lamp, in presence of intravascular sodium fluorescein suppressed the Ach dependent relaxation.
Moreover, after endothelial lesion the microvessels constricted in presence of Ach.
These findings support the importance of EDRF on the control of cerebrosvascular circulation in vivo so.
Peptidergic innervation -Research on the innervation of the cerebral blood vessels have disclosed peptidecontaining nerve fibers running along the pial blood vessels (e.g., substance P, VIP, pancreatic polypeptide, gastrin-releasing polypeptide, neurotensin, serotonin, neuropeptide Y, and somatostatin)37.38.
The origin of these fibers is still unknown.
They may be derived from the parasympathetic ganglions around the brain, but the question remains unresolved.
Other peptides such as cholecystokinin and proopiomelanocortin related peptides have had their action tested in the pial arterioles.
These studies demonstrated that such peptides are not important in cerebrovascular control when applied in physiological concentrations 38,56.
More is known about the action of VIP and substance P on cerebral vasculature. VIP-containing fibers reveal a spiral pattern similar to the muscle cell pattern. VIP-immunoreactive nerve terminals are present primarily in the inner layer of the adventitia.
The intraventricular and intra-arterial injection of VIP is followed by increased CBF. In addition, topical application of VIP to the cerebral arterioles and veins causes vasodilation 10.58.
The location of the VIP terminal suggest a direct action of VIP on the muscle itself. The dependence on endothelium for VIP-induced dilation awaits testing.
Substance P-containing fibers have a meshwork pattern in the cerebral blood vessels.
Ultrastructural observation has shown that substance P immunoreactivity terminal boutons are present in the outer layer of the adventitia apart from the smooth muscle cells.
Topical application of substance P to the pial arteriole and vein causes vasodilation 10. Intracerebral injection of substance P leads to an increase of the local CBF io. Thus substance P, as in the systemic circulation, also causes vasodilation in the cerebral vasculature.
This effect may very well be endotheliums dependent as is the case in other vascular beds 19.43.
EDRF AND THE CEREBROVASCULAR CHEMICAL REGULATION
The neurogenic control of cerebral circulation is not sufficient to explain physiological changes in CBF that take place under particular circumstances, such as variations in arterial blood pressure, changes in arterial PC0 2 and arterial P0 2 , and responses of the cerebral vasculature to oscillations in the brain metabolic status. As we described above, the sympathetic vasoconstriction is rather weak.
Furthermore, a generalized sympathetic or parasympathetic discharge would not control regional cerebral blood flow in areas of increased metabolism.
Thus, in addition to the factors that externally regulate cerebral circulation, and in addition to the neurogenic control, the cerebral vessels themselves possess the ability to regulate their diameter. In this section we will review these intrinsic control mechanisms influencing cerebral blood flow and their possible relationship with the endothelium dependent relaxing factor.
Arterial
PC0 2 and P0 2 cerebrovascular regulation -Arterial hypercapnia dilates cerebral blood vessels 50, increases CBF, and lowers cerebrovascular resistance (CVR^2 7 . Arterial hvpocapnia causes reverse changes in these variables. The effect of C0 2 is dependent on changes in hydrogen ion concentration of the extracellular fluid in the vicinity of the cerebral blood vessels l.
Molecular C0 2 and the bicar bonate ion do not appear to have inherent vasoactivity, as shown by the fact that marked changes in cerebrosoinal fluid PCO?
and bicarbonate ion concentration do not alter pial arteriolar caliber unless a change in pH is allowed to occur 32.
The effects of PG in several vascular beds appear to be EDRF mediated 19.43, 44 .
it has been suggested that PG may participate in the cerebrovascular C0 2 reactivity since the increase in CBF during hypercapnia was severely reduced following administration of indomethacin 47. Several PG (PGI 2 , PGE 2 , PGG 2 and PGD 2 ) and their precursor, arachidonic acid, dilate pial arterioles when applied topically.
In addtion, large cerebral vessels synthesize PQ n.12,23. However, the participation of PG in response to C0 2 seems unlikely, since following the administration of cyclooxygenase, a severe inhibitor of the vasodilator effect of arachidonic acid, the responses of pial vessels to arterial hypercapnia, hypocapnia, and hypoxia are not altered 2.28.
The absence of significant involvement of changes in PG synthesis in the responses to C0 2 or to hypoxia do not exclude the possibility that PG may be important mediators of other physiological or of abnormal responses in the brain circulation 58. There is evidence from experimental studies trat in pathological states such as mechanical brain injury and arterial hypertension, arachidonate is metabolized via the cyclooxyganase or lipoxyganase pathways.
Its metabolism by either pathway generates a powerful free oxygen radical which closely resembles the free hydroxyl radical in its reactivity !8,29. The action of this free radical on cerebral arterioles causes their vasodilator response to topical acetylcholine to be converted to vasoconstriction 25.
The vasodilation to topical acetylcholine is restored by topical application of superoxide dismutase and catalase.
These results show that superoxide and other radicals generated in patho logical conditions interfere with acetylcholine-induced endothelium dependent vasodi lation, probably because they destroy the endothelium derived relaxant factor 59. Although it is known that following the mentioned pathological states lesions exist in the cerebral arteriole endothelium 28,59,60, that responsiveness to changes in
PC0 2
is impaired, and that the Ach-induced vasodilation is converted to vasoconstriction, there is no direct evidence of causal relationship 31,
Further in vivo studies using the light/dye model of microvascular endothelial denudation 48,50, with topical phar macological manipulation and variation of systemic parameters may give insights as to the role of EDRF in cerebrovascular chemical regulation. Arterial hypoxia dilates pial arterioles, increases CBF, and lowers CVR 2 ?. These effects appear to be related to changes in local metabolism, since they are reverted by local application of oxyge nated fluorocarbons 28. Hypoxia-induced vasodilation is also dependent on the artery's previous tonus and the magnitude of the change in P0 2 43,44.
Metabolic cerebrovascular
regulation -There is a strong relationship between the level of functional activity and metabolic rate of the brain on the one hand, and global or regional CBF on the other 27,34.
Physiological activation of specific areas of the cortex by various types of sensory stimulation, or in association with motor activity, leads to an increased blood flow to the activated areas.
These areas also present increased metabolism 34.
it is generally believed that the relationship between CBF and metabolism is dependent on the production of vasodilator meta bolites by the neural cells.
CBF, in turn, is modulated by these metabolite levels in the perivasular space.
There are a large number of candidates that may serve as mediators of metabolic flow regulation. At present, adenosine, hydrogen ions and potassium ions appear to be the most promising candidates.
Adenosine is a strong dilator of pial vessels when applied in the perivascular space.
Brain adenosine con centration increases under conditions of arterial hypoxia, ischemia, or increased metabolic activity of the brain 28,45,46.
Although dependence on endothelium of the adenosine cerebrovascular relaxation has not been tested, data from other vascular beds suggest that it may not be EDRF mediated 43,44.
Cerebrovascular
auto regulation -Two basic mechanisms have been proposed to explain autoregulation in the brain: the myogenic mechanism, which holds that cerebral vessels are responsive to changes in transmural pressure, and the metabolic mechanism, the basic premise of which is that changes in cerebral vascular caliber are the result of alterations in the concentration of vasodilator metabolites.
These, in turn, are induced by alterations in blood flow secondary to the changes in pressure. The second theory is more likely 28. Adenosine concentration in the extracellular brain tissue has been demonstrated to rise quickly during hypotension 28.
Adjustment of pial arteriole diameter during variations in arterial blood pressure is not followed by changes in extracellular H+ and K+ activity 57. Chemical regulation and autoregu lation of CBF are not dependent on a and /3-adrenoceptors 5. Thus, adenosine, known to be an endothelium independent vasorelaxant in several vascular beds 43,44, j s a strong candidate for mediating of vasodilation during pressure autoregulation 45,46. It would also be of interest to test whether or not the viscosity autoregulation 42 j s EDRF mediated.
CONCLUSIONS
At this point in time there is no direct evidence that EDRF plays a vital role in cerebrovascular regulation.
However, indirect evidence suggests that EDRF may be involved in the modulation of cerebral sympathetic vasocontriction and parasym pathetic vasodilation.
There are no experiments that have tested the known chemical regulators of the cerebrovascular circulation in models of denuded endothelim cerebral vessels.
Findings in experimental models of pathological entities such as mechanical head injury, arterial hypertension and subarachnoid hemorrhage, known to have cerebrovascular endothelium lesions, suggest that EDRF serves an important function in regulating cerebral circulation under such circumstances.
In vitro studies of isolated large cerebral vessels and cultured cerebral microvessels 6, complemented with in vivo studies of light/dye denuded pial arteries, may clarify the role of endothelium dependent relaxing factor in the regulation of cerebral circulation.
